Glanbia (OTCMKTS:GLAPY) and AGEAS/S (OTCMKTS:AGESY) are both mid-cap consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends and valuation.
Institutional & Insider Ownership
0.3% of AGEAS/S shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Risk & Volatility
Glanbia has a beta of -0.19, indicating that its share price is 119% less volatile than the S&P 500. Comparatively, AGEAS/S has a beta of 0.76, indicating that its share price is 24% less volatile than the S&P 500.
This table compares Glanbia and AGEAS/S’s net margins, return on equity and return on assets.
Earnings & Valuation
This table compares Glanbia and AGEAS/S’s revenue, earnings per share and valuation.
AGEAS/S has higher revenue and earnings than Glanbia. AGEAS/S is trading at a lower price-to-earnings ratio than Glanbia, indicating that it is currently the more affordable of the two stocks.
This is a breakdown of recent ratings and recommmendations for Glanbia and AGEAS/S, as provided by MarketBeat.com.
Glanbia pays an annual dividend of $1.07 per share and has a dividend yield of 1.1%. AGEAS/S pays an annual dividend of $1.70 per share and has a dividend yield of 3.8%. Glanbia pays out 21.2% of its earnings in the form of a dividend. AGEAS/S pays out 48.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
AGEAS/S beats Glanbia on 9 of the 13 factors compared between the two stocks.
Glanbia plc operates as a nutrition company worldwide. It operates through three segments: Glanbia Performance Nutrition, Glanbia Nutritionals, and Glanbia Ireland Joint Venture. The Glanbia Performance Nutrition segment offers powders, bars and snacking food, and ready-to-drink beverages through various channels, including specialty retail, the Internet, and gyms, as well as food, drug, mass, and club channels. The Glanbia Nutritionals segment manufactures and sells cheese, dairy, and non-dairy nutritional ingredients, as well as vitamin and mineral premixes. The Glanbia Ireland Joint Venture segment produces a range of dairy ingredients and consumer products; and sells animal feed and fertilizers, as well as operates agricultural retail outlets. The company is also involved in the provision of property and land dealing, receivables management, management, property rental, business, financing, and agri trading services. It operates a portfolio of brands, including Optimum Nutrition, BSN, ABB, Isopure, Nutramino, thinkThin, Amazing Grass, and Body & Fit. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
ageas SA/NV, together with its subsidiaries, engages in insurance business in Europe and Asia. The company primarily offers property, casualty, and life insurance products, as well as pension products; and reinsurance products. Its life insurance products include risks related to the life and death of individuals; and non-life insurance products comprise accident and health, motor, fire and other damage to property, and other insurance products. The company serves private individuals, as well as small, medium-sized, and large companies through independent brokers and the bank channels. ageas SA/NV was founded in 1824 and is based in Brussels, Belgium.